H. Bläker

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial.

C. Denkert, H. Oettle, H. Riess, 2015, European journal of cancer.

Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis

P. Malfertheiner, F. Lordick, H. Lippert, 2021, Journal of Cancer Research and Clinical Oncology.

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study.

B. Dörken, C. Denkert, M. Dietel, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study

J. Eberth, F. Lordick, R. Thieme, 2022, Journal of Cancer Research and Clinical Oncology.

S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple

S. Suerbaum, J. Nattermann, A. Stallmach, 2015, Zeitschrift für Gastroenterologie.

Gemcitabine: results from the CONKO-001 study

B. Dörken, C. Denkert, M. Dietel, 2014 .

SPARC expression in resected pancreatic cancer patients treated with gemcitabine : results from the CONKO-001 study

M Dietel, C Denkert, B. Dörken, 2014 .

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

C. Denkert, H. Oettle, H. Riess, 2021, Frontiers in Oncology.